Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

460 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing's family tumours.
Luksch R, Grignani G, Fagioli F, Brach del Prever A, Podda M, Aliberti S, Casanova M, Prete A, Hanau G, Tamburini A, Allione P, Tienghi A, Ferrari S, Collini P, Marchianò A, Gandola L, Aglietta M, Madon E, Picci P, Fossati-Bellani F. Luksch R, et al. Among authors: fagioli f. Eur J Cancer. 2007 Mar;43(5):885-90. doi: 10.1016/j.ejca.2006.09.027. Epub 2007 Jan 24. Eur J Cancer. 2007. PMID: 17254770
Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group.
Bonetti F, Zecca M, Pession A, Messina C, Montagna D, Lanino E, Fagioli F, Santoro N, Prete A, Cesaro S, Rondelli R, Giorgiani G, De Stefano P, Locatelli F. Bonetti F, et al. Among authors: fagioli f. J Clin Oncol. 1999 Dec;17(12):3729-35. doi: 10.1200/JCO.1999.17.12.3729. J Clin Oncol. 1999. PMID: 10577844 Clinical Trial.
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease.
Aglietta M, Montemurro F, Fagioli F, Volta C, Botto B, Cantonetti M, Racanelli V, Teofili L, Ferrara R, Amadori S, Castoldi GL, Dammacco F, Levis A. Aglietta M, et al. Among authors: fagioli f. Cancer. 2000 Jan 15;88(2):454-60. doi: 10.1002/(sici)1097-0142(20000115)88:2<454::aid-cncr28>3.0.co;2-q. Cancer. 2000. PMID: 10640980 Clinical Trial.
ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells.
Valabrega G, Fagioli F, Corso S, Madon E, Brach del Prever A, Biasin E, Linari A, Aglietta M, Giordano S. Valabrega G, et al. Among authors: fagioli f. Br J Cancer. 2003 Feb 10;88(3):396-400. doi: 10.1038/sj.bjc.6600735. Br J Cancer. 2003. PMID: 12569382 Free PMC article.
460 results